ESR1 and triple-negative breast carcinoma: Our study focuses on the energy metabolism of three cell lines: triple-negative breast cancer (MDA-MB-231), estrogen-receptor lacking breast cancer (MCF7), and normal breast epithelial cells (MCF10A) with caffeine, cisplatin, or a combination of the two.